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SUMMARY
Organ tissue damage is a key contributor to host morbidity and mortality following
infection with microbial agents. Severe immune responses, excessive cellular recruit-
ment and necrosis of cells all play a role in disease pathology. Understanding the
pathogenesis of disease can aid in identifying potential new therapeutic targets or
simply act as a diagnostic tool. Burkholderia pseudomallei is a Gram-negative bac-
terium that can cause acute and chronic diseases. The BALB/c mouse has been
shown to be highly susceptible to aerosol challenge with B. pseudomallei and hence
acts as a good model to study the acute and potentially lethal form of the disease
melioidosis. In our study, BALB/c mice were challenged and culled at predetermined
time points to generate a pathological time course of infection. Lung, liver and
spleen were subjected to pathological and immunohistochemical analysis. The num-
ber and type of microscopic lesions within each organ, as well as the location and
the mean percentage of neutrophils, B cells, T cells and Burkholderia capsule antigen
within the lesions, were all characterized during the time course. Neutrophils were
determined as the key player in tissue pathology and generation of lesions, with B
cells playing an insignificant role. This detailed pathological assessment increases our
understanding of B. pseudomallei disease.
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Burkholderia pseudomallei is the causative agent of the dis-
ease melioidosis. It is an intracellular Gram-negative bac-
terium that has the ability to infect numerous different cell
types (David et al. 2015) and is naturally resistant to many
antibiotics, due to efflux pumps (Mima & Schweizer 2010;
Rhodes & Schweizer 2016).
Melioidosis is an emerging tropical disease, endemic to
South-East Asia and Northern Australia (Aldhous 2005;
Kaestli et al. 2009; Valade et al. 2009). Burkholderia pseu-
domallei is known to cause diseases in humans via the aero-
sol route and via cutaneous lesions (Leelarasamee 1998).
Depending on challenge dose and route of infection, it can
either cause an acute disease where the immune response is
inadequate and mortality rates are high or a chronic infec-
tion where the pathogen can reside for long times in local-
ized regions (Wiersinga et al. 2006, 2009).
The natural ability of B. pseudomallei to infect via the
aerosol route and its low challenge dose have also made this
bacterium a potential biothreat agent of concern (Gilad
et al. 2007). Currently, there is no licensed vaccine to pre-
vent infection, and antibiotic treatment is suboptimal and
often time-consuming (Dance 2014). Single antibiotic dosing
regimens are only partially effective, and combination treat-
ments have to be given for prolonged periods, up to
6 months to clear the infection completely (Srinivasan et al.
2001). Therefore, there is a continued requirement to
develop new therapies and thus a greater understanding of
the disease.
Several animal models have been developed over the years
to determine the host–pathogen interactions. The mouse
model has been the most characterized with the BALB/c
mouse being very susceptible to infection and the C57BL/6
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mouse strain being more resistant (Barnes et al. 2001). This
has led to the BALB/c mouse being mainly used for acute dis-
ease studies and the C57BL/6 strain for chronic models (Lea-
key et al. 1998; Hoppe et al. 1999; Liu et al. 2002; Barnes &
Ketheesan 2005; Conejero et al. 2011; Bearss et al. 2017).
Despite growing research into this pathogen, there are still
some gaps in the knowledge of the organ pathology and
lesion development associated with the disease, although it
has been documented that excessive immune response
postinfection with B. pseudomallei is a significant contribu-
tor to host mortality (Ulett et al. 2000; Tan et al. 2008).
Therefore, controlling tissue pathology and organ damage
caused by an overactive immune response could represent
an appropriate therapeutic strategy where an immunomodu-
latory drug may control the excessive inflammation and an
antibiotic can control the bacterial spread (Laws et al.
2015). Preliminary histological studies have demonstrated in
the BALB/c mouse that there are foci of acute inflammation
and necrosis in the lung, liver and spleen following infection
with B. pseudomallei BRI strain (Barnes et al. 2001; Lever
et al. 2009). Additional histological studies have focused on
the chronic C57BL/6 mouse model of infection with samples
taken at day 20 and day 60 p.i, indicating that the spleen
and liver are the most susceptible organs to bacterial growth
and tissue destruction (Conejero et al. 2011).
In this study, we sought to carry out a detailed
histopathological and immunohistochemical analysis using
the BALB/c acute model and the B. pseudomallei K96243
human clinical isolate strain. Analyses were carried out at
multiple time points during the short course of infection.
Material and methods
Experimental design
Forty male BALB/c mice (Charles River, UK), six to eight
week old, were included in this study, split over two identi-
cal but independent experiments. Mice were randomly
assigned into cages and transferred to a high-containment
Class III rigid isolator, where they were given unlimited
access to food and water. Thirty mice were challenged with
the B. pseudomallei strain K96243 by aerosol, using a Hen-
derson-type apparatus (Druett 1969) and a Collison nebu-
lizer (May & Harper 1957), and ten were left as na€ıve
controls. Bacteria were grown in Luria broth at 37°C on a
rotary platform. Animals received a lethal dose ~ 20 9
LD50 with an average challenge dose of 146 CFU. The
challenge dose is the average calculated retained dose per
mouse. Mice were sprayed for a total of 10 minutes with a
2-minute subsamples (impinger) collected for bacterial enu-
meration. The impinger sample was serially diluted and pla-
ted in triplicates.
At 24 hpi, infected mice showed minor ruffling and
hunching. At 48 hpi, ruffling and hunching were more pro-
nounced and signs of conjunctivitis appeared. At 60 hpi,
infected mice were either at or close to humane end point.
Mice were culled at predetermined time points (TP1 = 24
hpi, TP2 = 48 hpi and TP3 = 60 hpi). Ten infected mice
were culled at each time point while five na€ıve controls were
culled at 24 hpi and five at 60 hpi.
Histopathology
The lung, liver and spleen were all processed within less than
1 hour post mortem and immersed in neutral sodium salt-buf-
fered formalin. Samples were fixed for 1 month and embed-
ded in paraffin wax, and 4-lm sections were cut, dewaxed
and rehydrated through xylene and alcohols to be finally
washed in running tap water. Haematoxylin and eosin
(H&E) stain was used for the histopathological analysis.
Immunohistochemistry
The immunohistochemical detection of B. pseudomallei was
performed with a murine monoclonal antibody (3VIE5) that
reacts with a capsular polysaccharide of B. pseudomallei.
For the characterization of cell composition of lesions, a rat
monoclonal anti-Ly-6G (Invitrogen, Darmstadt, Germany),
a rat monoclonal anti-CD45R-B220 (Invitrogen) and a rab-
bit polyclonal anti-CD3 (Dako) were used as immunomark-
ers for neutrophils, B cells and T cells respectively.
Consecutive 4-lm sections were dewaxed, rehydrated and
placed in a fresh solution of 3% hydrogen peroxide in
methanol for 15 minutes to block endogenous peroxidase
activity. Samples were then washed for 10 minutes in tap
water before being clipped into Shandon Sequenza clips
(Thermo Scientific, Loughborough, Leistercershire, UK).
After slides were mounted, epitope demasking was per-
formed through enzymatic digestion, using a solution of 2%
proteinase K (Dako) in Tris-buffered saline (0.05 mol/L
Tris–HCl pH 7.5 to 7.7). Then, the tissue sections were
washed for 10 minutes with Tris-buffered saline (TBS)
(0.85% NaCl, 0.0605% Tris, adjusted to pH 7.5 using 1M
HCl), and then, 190 ll of Universal BlockerTM Blocking Buf-
fer in TBS (Thermo Scientific) was added to the slides as
blocking agent. After twenty minutes, 190 ll of the primary
antibody was added. The incubation time as well as the con-
centration varied for each primary antibody used (Table 1).
The Vector M.O.M. Immunodetection kit (Vector, Peterbor-
ough, UK) was used for the anti-Burkholderia antibody fol-
lowing the manufacturers’ indications. For anti-Ly-G6, anti-
CD45R-B220 and anti-CD3 antibodies, after two washes
with TBS buffer, 190 ll of biotinylated link antibody and
link block (Thermo Scientific) was added (Table 1), followed
by two further buffer washes, 30 minutes later. Primary and
secondary antibody binding was amplified using Ultra-Sensi-
tive ABC Peroxidase Rabbit IgG Staining Kit (Thermo Scien-
tific) and visualized using the Vector NovaREDTM Substrate
Kit (Vector Laboratories, Burlingame, CA, USA). Unbound
conjugate was removed prior to chromogen application with
two buffer washes. Slides were then washed in purified
water, removed from the coverplates and placed in a rack.
Samples were rinsed with tap water for five minutes, before
being placed in Mayer’s Haematoxylin counterstain,
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followed by a further wash in tap water. Finally, sections
were dehydrated, cleared and mounted for analysis.
Image analysis and statistics
Immunolabelled sections were analysed using light microscopy
and digital image analysis (Nikon NIS-Br, Nikon, Japan).
The area of tissue with lesions was calculated using a full sec-
tion of lung, liver and spleen. The slides were examined with the
940 objective to give a final magnification of9400, to ascertain
the percentage of immunostained cells within the lesion.
To compare the mean number and type of lesions per
time point, nonparametric Mann–Whitney’s U-test was used.
Data were considered statistically significant when P < 0.05.
For immunohistochemistry, the mean expression of anti-
CD3 antibody was compared for type of lesions and time
points. Differences were considered significant at P < 0.05.
The results of immunohistochemical analysis are expressed
as mean  standard deviation (S.D).
Due to the staining characteristics or the localization of
the immunolabelled cells, it was not possible to perform the
image analysis for the antibodies anti-Burkholderia, Ly-6G
and CD45B-220. For this reason, the analysis of these anti-
bodies has been made in a qualitative way.
All the statistical analyses were conducted using SPSS 19
software package (SPSS Inc., Chicago, IL, 60606, USA) and
GraphPad Prism 4.0 (San Diego, CA, USA).
Ethical approval
All procedures involving animals were conducted under pro-
ject licences approved by internal ethical review and the
Home Office, and in accordance with both the Animal
(Scientific Procedures) Act (1986) and the 1989 Codes of
Practice for the Housing and Care of Animals used in Scien-
tific Procedures.
Results
Time course histopathology in the lung
Lung lesions were classified into three categories according
to cellular composition and evolution stage: type I,
characterized by a discrete inflammatory foci of macro-
phages, lymphocytes and some neutrophils, usually close to
blood vessels and/or bronchioles (Figure 1a); type II, defined
as round lesions with areas of granulomatous pneumonia
with similar distribution to those in type 1, but containing
epithelioid macrophages and more neutrophils, some of
which were necrotic (Figure 1b); and type III defined as
large pyogranulomas mainly formed by neutrophils and with
a necrotic centre surrounded by epithelioid macrophages,
some lymphocytes and plasma cells (Figure 1c). The total
number of lesions of each type was counted in a full lung
section per animal.
After 24 hpi, type II lesions were predominant in the lung
followed by type I lesions. Type III lesions were exclusively
observed in one animal at 24 hpi, while other animal did
not show lesions at this time point. At 48 and 60 hpi, there
was an increase in the total number of lesions, especially
due to a statistically significant increase in type III lesions.
Finally, at the last time point (60 hpi), the total number of
lesions as well as the lesion types remained stable compared
with 48 hpi (Figure 2).
Time course histopathology in the liver
Lesions in the liver were classified, similar to lung, into three
categories according to necrosis extension. Type I was charac-
terized by a minimal foci of necrosis mainly due to infiltrated
neutrophils (Figure 1d); type II was defined as moderate foci
of necrosis formed by mixed inflammatory cells (Figure 1e);
and type III was characterized by more extensive foci of
necrosis frequently due to coalescent lesions (Figure 1f).
The total number of lesions of each category was counted
in a full liver section per animal. Only two animals showed
type I lesion in the liver at 24 hpi. However, there was an
exponential increase in the number of lesions at 48 hpi, with
type I lesions being the most observed. There was an
increase in the number of all types of lesions at 60 hpi when
compared to 24 and 48 hpi (Figure 3).
Time course pathology in the spleen
The spleen showed a marked disruption of the normal tissue
architecture. Lesions were typically pyogranulomatous, with
Table 1 Antibodies and reagents used for immunohistochemistry
Primary antibody Antibody type Dilution Supplier
Epitope demasking
method Link antibody (dilution) Buffer
CD3 Rabbit vs Human
CD3 (Polyclonal)
1/500 Dako (A0452) Proteinase K (DAKO) Goat vs Rabbit (1/1000) TBS
CD45R-B220 Rat vs Mouse
CD45R-B220
(Monoclonal)
1/100 Invitrogen (RA3-6B2) Proteinase K (DAKO) Goat vs Rat (1/200) TBS
Ly-6G Rat vs Mouse
Ly-6G (Monoclonal)
1/25 Invitrogen (RB6-8C5) Proteinase K (DAKO) Goat vs Rat (1/200) TBS
Anti-Burkholderia Mouse vs Burkholderia
pseudomallei
(Monoclonal)
1/50 DSTL Lever
et al. (2009)
Proteinase K (DAKO) Vector M.O.M.
biotinylated mouse
IgG (1/250)
TBS
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abundant neutrophils and macrophages, mainly within the
red pulp but also in the white pulp. No differentiation into
types was performed for the splenic lesions. The percentage
of tissue damaged in a full spleen section per animal was
estimated to calculate the organ pathology score.
Only one animal showed a single necrotic focus at 24 hpi.
There was a statistically significant increase in the
percentage of affected tissue at 48 hpi and 60 hpi when
compared to 24 hpi with all animals showing lesions at this
time point. At 60 hpi, also there was an increase in the per-
centage of affected tissue compared with 48 hpi, which was
not statistically significant (Figure 4).
(a) (b) (c)
(d) (e) (f)
* *
Figure 1 (a) H&E lung section from a type I lesion (2009). Inflammatory foci of macrophages, lymphocytes and some neutrophils
close to a blood vessel (*). (b) H&E lung section from a type II lesion (1009). Foci of granulomatous pneumonia containing some
epithelioid macrophages and neutrophils, some of which were necrotic (arrow). (c) H&E lung section from a type III lesion (1009).
Large pyogranuloma adjacent to a bronchiole (*) formed by neutrophils with a necrotic centre (arrow) surrounded by few
macrophages, lymphocytes and plasma cells. (*). (d) H&E liver section from a type I lesion (2009). Minimal foci of necrosis mainly
due to infiltrated neutrophils (arrow). (e) H&E liver section from a type II lesion (2009). Moderate foci of necrosis formed by mixed
inflammatory cells (arrow). (f) H&E liver section from a type III lesion (2009). Extensive foci of necrosis due to coalescent lesions (*).
I I I I II I I I I II I I I I II
0
20
40
60
Number of lesions in the lung
24 hpi
*
48 hpi 60 hpi
*
Figure 2 Time course histopathology in the lung. Total number
of each type of lesions (I, II and III) observed per time point. At
48 and 60 hpi (TP2 and TP3), there was a statistically
significant increase (P < 0.05) in the total number of type III
lesions (*) when compared to 24 hpi (TP1).
I II III I II III I II III
0
40
80
120
Number of lesions in the liver
24 hpi
*
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*
*
*
Figure 3 Time course histopathology in the liver. Total
number of each type of lesions (I, II and III) observed per
time point. An exponential increase in the number of lesions
was observed at 48 hpi when compared to 24 hpi. At 60
hpi, there was an increase in the number of lesions when
compared to 24 and 48 hpi, significantly higher for type I
and II lesions (*P < 0.05).
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Immunohistochemical analysis of Burkholderia spp.
antigen and cell populations within lesions
Anti-Burkholderia spp. antibody. Immunohistochemistry
against Burkholderia spp. capsular antigen showed extensive
positive staining within lung, liver and spleen lesions. The
positive reaction was located mainly within the cytoplasm
of macrophages in type I lung lesions at 24 hpi (Figure 5a).
However, staining in the lung became more extensive over
time as infection progressed and antigen was located within
the cytoplasm of both macrophages and neutrophils associ-
ated with areas of consolidation and necrosis in type II and
III lesions (Figure 5b).
Positive reaction was also observed within both degener-
ated and viable macrophages and neutrophils surrounding
the areas of necrosis in liver and spleen pyogranulomas (Fig-
ure 5c, d). No Burkholderia spp. capsular antigen was
detected in uninfected controls.
Neutrophils (Ly-6G). High numbers of Ly-6G+ cells were
detected in all lesion types in the lung. Positive cells were
mainly observed within the lesion but also in the adjacent
tissue (Figure 6a). Fewer positive cells were observed within
the centre of the lesions, especially in the larger ones (Fig-
ure 6b). Fewer Ly-6G+ cells were detected in hepatic and
splenic lesions when compared to the lungs.
T lymphocytes (CD3). Few CD3 + cells were sparsely dis-
tributed within lesions independent of the lesion type. A
small number of CD3 + cells were observed in lung lesions
(Figure 6c, d). However, a statistically significant higher
number of CD3 + cells were observed in type I and II
lesions at 24 hpi when compared to 48 hpi and 60 hpi (Fig-
ure 7).
B lymphocytes (CD45R-B220). B lymphocytes do not seem
to be involved in the development of B. pseudomallei lesions
24 hpi 48 hpi 60 hpi
0
10
20
30
40
50
*
*
Area of spleen with lesion
%
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f a
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a
Figure 4 Time course pathology in the spleen. Percentage of
spleen area affected per time point. A statistically significant
(P < 0.05) increase in the percentage of affected tissue at 48
and 60 hpi when compared to 24 hpi was observed (*).
(a) (b)
(d)(c)
*
Figure 5 Immunohistochemically stained sections against a capsular polysaccharide of Burkholderia pseudomallei. (a) Type I lung
lesions (arrow) at 24 hpi (1009) with positive reaction mainly within the cytoplasm of macrophages and neutrophils. (b) Extensive
type III lesion at 60 hpi (1009) showing the antigen within the cytoplasm of macrophages and neutrophils associated with areas of
consolidation and necrosis (*). (c) Positive immunohistochemical reaction within both degenerated and viable macrophages and
neutrophils surrounding a focus of necrosis in a type II lesion (2009) in the liver (arrow) and a small type I lesion (arrowhead). (d)
Positive immunohistochemical reaction within the spleen at 60 hpi, mostly affecting the red pulp (arrows) (1009).
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in our BALB/c model, as they were not observed in any type
of lesions independently of the time point analysed. The
number of B cells present in the adjacent healthy tissue was
also small (Figure 6e), but occasionally they formed aggre-
gates (Figure 6f). B cells were not observed in the hepatic
lesions.
Discussion
The organ pathology associated with B. pseudomallei infec-
tion is still not clearly understood. The BALB/c mouse
model has been proposed as an appropriate model to evalu-
ate the acute form of melioidosis in humans. However, the
histopathology and immunopathology associated with this
disease in BALB/c mice has been analysed infrequently
(b)
(c) (d)
(e) (f)
*
(a)
Figure 6 Immunohistochemical detection of Ly-6G+ neutrophils (a, b), CD3 + cells (c, d) and CD45R-B220 cells (e, f). (a) Ly-6G
positive reaction in a type II lesion at 48 hpi (2009). Positive cells were mainly observed within the lesion but also in the adjacent
tissue (arrow). (b) Ly-6G+ cells in a type III lesion at 48 hpi (2009). High amount of Ly-6G+ cells with a lighter staining in the
centre of the lesion (*). (c) A low number of CD3 + cells were observed in lung lesions. Scarce positive cells (arrow) in a type II
lesion at 48 hpi (2009). Positive cells were mainly observed within the lesion but also in the adjacent tissue. (d) Very few CD3 +
cells at the periphery of a type III lesion (arrow) at 60 hpi (2009). (e) Immunohistochemical detection of very few B cells (CD45R-
B220 + ) within healthy tissue adjacent to a type II lesion (arrow) at 24 hpi (2009) (arrow). (f) 9Aggregate of B cells (arrow)
forming a ‘nest’ close to a main bronchus and near to a type II lesion (2009) at 48 hpi.
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0.0
0.2
0.4
0.6
0.8
1.0
CD3+ cells within lung lesions
24 hpi
*
48 hpi 60 hpi
*
*
%
 +
ve
 s
ta
in
ed
 a
re
a
*
Figure 7 Immunohistochemical detection of CD3 + cells within
lung lesions as percentage of immunostained area. A statistically
significant higher number of CD3 + cells was observed in type I and
II lesions at 24 hpi when compared to 48 and 60 hpi (*P < 0.05).
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(Barnes et al. 2001; Lever et al. 2009; Kager et al. 2014;
Bearss et al. 2017).
Our study shows a detailed histopathological and
immunohistochemical characterization of lung, liver and
spleen pathologies using the BALB/c mice acute infection
model and the B. pseudomallei K96243 human clinical iso-
late strain.
In our study, we found that 9/10 animals showed pyo-
granulomatous lesions within the lung as early as 24 hpi.
These results are in line with previous studies demon-
strating the high susceptibility of this mouse strain and
how quickly the disease can evolve to the development
of severe lesion types even at the first 24 hrs, as we
found one animal showing type III lesions at this time
point (TP1).
Previous studies described an exponential bacterial mul-
tiplication within the lung over the first 24 hpi, before
the rate of replication became more gradual (Jeddeloh
et al. 2003; Lever et al. 2009). This disease progression
pattern is reflected within the microscopic lesions observed
in our study, with an exponential increase in the number
of lesions at 48 hpi (TP2), being later more stable at 60
hpi (TP3).
Similar patterns of initial exponential growth have been
described in the liver and spleen once the bacteria are seeded
from the lung. At this point, animals died because the
damage in these organs became more severe while the rate
of microorganism replication remained steady (Lever et al.
2009; Conejero et al. 2011).
In the study from Lever et al. (2009), no hepatic lesions
were detected at 24 hpi and only two small foci of necro-
sis were shown at 48 hpi in the liver. In the same study,
the lesions in the spleen described as multifocal acute
necrotizing splenitis were not shown until 48 and 72 hpi.
In contrast, in our study, we found initial lesions in the
liver of two animals as early as 24 hpi (TP1), including
the one animal showing type III lesions in the lung and
splenic lesions at this time point. Similar changes in the
liver and spleen were observed by Barnes et al. (2001),
with an early neutrophil influx to the organs causing
small inflammatory foci at 24 hpi. Furthermore, we
observed an exponential increase in the number of lesions
in both liver and spleen, at 48 hpi which continued at 60
hpi although the challenge dose used in the Lever et al.
(2009) study (100 cfu) was similar to the one used in our
study.
Intense immunostaining for the capsular polysaccharide
antigen of B. pseudomallei was observed within lesions in
all tissues. The extension and intensity of the staining were
higher in large lesions, which could reflect the sustained bac-
terial growth at these sites.
After analysing the cell composition of microscopic lesions
by immunohistochemistry, we have found neutrophils
(Ly-6G+ cells) as the most frequent cells. In a recent com-
parative virulence study (Massey et al. 2014), an important
increase (around 300%) in the number of neutrophils in
peripheral blood was observed in infected animals.
Furthermore, previous studies have demonstrated that acti-
vated neutrophils are rapidly recruited to the lungs after a
high-dose pulmonary challenge with B. pseudomallei using
flow cytometry (Easton et al. 2007) or histopathology (Bar-
nes et al. 2001; Kager et al. 2014). This has also been
described in another study highlighting the presence of
macrophages and natural killer cells in the lesions (Bearss
et al. 2017). In line with this finding, histological analysis of
tissue from human patients with melioidosis has demon-
strated the presence of abundant neutrophils together with a
small number of macrophages within lesions (Wong et al.
1995).
It has been suggested that neutrophils play a role in
early resistance against B. pseudomallei infection (Breit-
bach et al. 2006). However, our findings are more in
agreement with those of the authors who have suggested
that neutrophils are not sufficient to control the infection
despite their recruitment to the infection site (Massey
et al. 2014). In addition, Massey et al. (2014) found an
important increase in IL-17 in infected animals compared
with non-infected control animals. This cytokine is
recognized as the main mechanism whereby Th17 cells
contribute to tissue damage due to prolonged neutrophil
recruitment (Fogli et al. 2013). This mechanism may also
be involved in the development of microscopic lesions
observed in our study.
There is growing literature supporting the view that an
excessive immune response, leading to exaggerated cellular
recruitment, is a major contributor to morbidity and ulti-
mately mortality in a number of different infections (D0elia
et al. 2013). Furthermore, it has been shown that dampen-
ing down the immune response during Burkholderia spp.,
infection can increase survival. Inhibition of IL-1beta, COX-
2 and HMGB1 has been shown to be beneficial in models of
melioidosis (Ceballos-Olvera et al. 2011; Asakrah et al.
2013; Charoensup et al. 2014; Laws et al. 2015; ).
It has also been demonstrated that robust T-cell functions
are paramount in protection against B. pseudomallei infec-
tion and that IFN-g and the IFN-g-inducing cytokines IL-12
and IL-18 are essential for initial resistance (Haque et al.
2006). In our study, the number of CD3 + cells within the
lesions was quite low. We found a statistically significant
higher presence of CD3 + cells within early lesions at 24
hpi, which could represent a first attempt to control the dis-
ease. However, the presence of CD3 + cells was minimal at
48 hpi and 60 hpi, where lesions were mainly formed by
neutrophils and some macrophages. This could be one of
the reasons why BALB/c mice fail to control the disease and
die in <5 days after infection (Lever et al. 2009). Indeed, the
importance of T cells later during infection has been shown
in a B. mallei model (Rowland et al. 2010).
A recent study showed that strong CD4 + and CD8 +
T-cell responses are required for patients to survive acute
melioidosis (Jenjaroen et al. 2015). CD4 + T cells were also
reported to protect mouse in the late stage of B. pseudoma-
llei infection (Haque et al. 2006). We found a slight increase
(not statistically significant) in the presence of CD3 + cells
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in type I lesions at TP3 that would not seem to be enough
to establish a late response.
B lymphocytes were not observed in any type of lesions in
our study independent of the time point analysed, although
occasional aggregates of B cells were observed within
healthy lung tissue adjacent to lesions. This may be due to
the fact that the lesional pattern is too acute for the inter-
vention of this cell population.
This finding has been described in other diseases caused
by intracellular pathogens such as Mycobacterium bovis
(Salguero et al. 2016). However, the role of these ‘nests’ in
the host immune response is not well understood.
The histopathological and immunohistochemical analysis
of the lesions found in this BALB/c mice model demon-
strates the high susceptibility of this mouse strain to acute
melioidosis. This is corroborated by the highest presence of
B. pseudomallei antigen within the largest lesions, which are
deficient in a T-cell response and dominated by the presence
of neutrophils. The high recruitment of neutrophils seems to
be responsible for most of the tissue damage observed
within histopathological lesions.
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